Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients
Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
GEM05 for Patients With Multiple Myeloma Under 65 Years
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS
VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma
A Phase II Trial of Combined Weekly Bortezomib and Tositumomab I-131 in Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
† Indicates status has not been verified in more than two years